Titan Pharmaceuticals
TTNP
#10362
Rank
HK$48.06 M
Marketcap
HK$36.13
Share price
-3.76%
Change (1 day)
17.14%
Change (1 year)

EPS for Titan Pharmaceuticals (TTNP)

EPS in 2025 (TTM): -HK$34.26

According to Titan Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -HK$34.41. In 2023 the company made an earnings per share (EPS) of -HK$58.08 an increase over its 2022 EPS that were of -HK$119.05.

EPS history for Titan Pharmaceuticals from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-HK$34.26
2023-HK$58.08-51.22%
2022-HK$119.05-15.61%
2021-HK$141.08-81.37%
2020-HK$757.12-77.52%
2019-HK$3,369-56.32%
2018-HK$7,712-59.51%
2017-HK$19,050-371.81%
2016HK$7,008-144.35%
2015-HK$15,801300%
2014-HK$3,950-121.54%
2013HK$18,340-151.38%
2012-HK$35,693-11.54%
2011-HK$40,349188.89%
2010-HK$13,967-10%
2009-HK$15,519
2007-HK$63,627-2.38%
2006-HK$65,179-39.13%
2005-HK$107,079-16.87%
2004-HK$128,806-22.43%
2003-HK$166,0514.9%
2002-HK$158,29161.9%
2001-HK$97,768-13.7%
2000-HK$113,28765.01%
1999-HK$68,656-35.87%
1998-HK$107,061-1824.71%
1997HK$6,208-102.4%
1996-HK$259,163

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$87.29-353.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$57.69-267.65%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vanda Pharmaceuticals
VNDA
-HK$11.13-67.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
HK$0.24-100.68%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-HK$1.96-94.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-HK$26.49-23.01%๐Ÿ‡บ๐Ÿ‡ธ USA